Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ROIBACK
New York, New York, USAen.roiback.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Roivant has achieved multiple FDA approvals since its founding in 2014, with over forty investigational drugs developed through its family of companies. It leverages a unique hub-and-spoke model to rapidly develop and commercialize medicines via focused subsidiaries ("Vants"). Recent highlights include the sale of an inflammatory bowel disease drug to Roche for $7 billion after acquiring it from Pfizer for $45 million plus development costs. The company continues to advance programs in autoimmune diseases, dermatology, pulmonary hypertension, rare diseases, and more.
- Therapeutic areas
- Men's HealthPulmonologyImmunologyDermatologyGastroenterologyCardiovascularNeurology
- Modalities
- Small moleculeMonoclonal antibodyGene therapyEnzyme replacement therapyRNA therapyDrug-device combination
- Industry
- Biotech
02
Partnerships
Beyond the preview
Go deeper on ROIBACK.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ROIBACK.